Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
15.37
+0.47 (3.15%)
At close: May 30, 2025, 4:00 PM
15.75
+0.38 (2.47%)
After-hours: May 30, 2025, 6:38 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Alignment Healthcare stock ranges from a low of $9.00 to a high of $23. The average analyst price target of $17.45 forecasts a 13.53% increase in the stock price over the next year.
Price Target: $17.45 (+13.53%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alignment Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 3 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 9 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +10.61% | May 2, 2025 |
| Baird | Baird | Buy Maintains $17 → $22 | Buy | Maintains | $17 → $22 | +43.14% | Apr 15, 2025 |
| Stifel | Stifel | Strong Buy Maintains $18 → $23 | Strong Buy | Maintains | $18 → $23 | +49.64% | Apr 8, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | +10.61% | Mar 6, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $14 → $21 | Buy | Maintains | $14 → $21 | +36.63% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
3.87B
from 2.70B
Increased by 42.96%
Revenue Next Year
4.86B
from 3.87B
Increased by 25.77%
EPS This Year
-0.35
from -0.67
EPS Next Year
-0.08
from -0.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.0B | 5.2B | 5.4B | ||
| Avg | 3.9B | 4.9B | 5.2B | ||
| Low | 3.7B | 4.4B | 4.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 48.5% | 34.6% | 11.1% | ||
| Avg | 43.0% | 25.8% | 6.4% | ||
| Low | 35.8% | 14.6% | 0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.28 | 0.11 | 0.45 | ||
| Avg | -0.35 | -0.08 | 0.14 | ||
| Low | -0.42 | -0.35 | -0.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.